A Pharmacoepidemiological Study to Examine Patient Characteristics, Drug Utilization Pattern and Crude Incidence Rates of Selected Outcomes in New Users of Ticagrelor, Clopidogrel and Prasugrel in National Swedish Registries
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2016
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
- Indications Thrombosis
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 23 Apr 2015 Planned number of patients changed from 6000 to 7200 as reported by ClinicalTrials.gov record.
- 23 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 17 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.